Alector, Inc. ALEC
Set alert
At close · Oct 30
After hours · Oct 30, 5:30 PM ET
- YTD
- +41.67%
- 1 year
- +45.39%
- Open
- 2.20
- Prev close
- 2.24
- Mkt cap
- 246.76M
- Vol
- 1.11M
- Avg vol
- 3.32M
- EPS
- -1.09
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.09
- High
- 2.25
- Forward P/E
- -1.25
- Beta
- 0.66
- Short ratio
- 3.92
- Inst. own
- 95.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 3.81
- 200-d avg
- 4.92
- 1y target
- 5.51
5D chart
Signals (63)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:00 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:45 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:35 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:55 PM | 5 days ago |
| RSI: Overbought | Oct 27, 12:20 PM | 5 days ago |
| RSI: Overbought | Oct 27, 11:25 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:35 PM | 6 days ago |
| RSI: Oversold | Oct 26, 3:05 PM | 6 days ago |
| RSI: Oversold | Oct 26, 2:45 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:35 PM | 6 days ago |
| RSI: Overbought | Oct 26, 1:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:00 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
| MACD: Sell Signal | Oct 26, 10:35 AM | 6 days ago |
| RSI: Overbought | Oct 26, 10:15 AM | 6 days ago |
| MACD: Buy Signal | Oct 23, 3:10 PM | 1 week ago |
| RSI: Overbought | Oct 23, 3:10 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 2:45 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 2:00 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 1:25 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 1:00 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 12:50 PM | 1 week ago |
News
3 days ago zacks.com
Will Alector (ALEC) Report Negative Q3 Earnings? What You Should Know
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 weeks ago globenewswire.com
Alector Announces Pricing of Underwritten Offering
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (“Alector,” Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating…
-
2 weeks ago benzinga.com
Fastenal To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday
Analysts raised targets for TSM, MRNA, ALEC and WMT; cut AZZ, ARRY and ALGN targets, upgrading ARRY/WMT and downgrading ALGN.
-
2 weeks ago benzinga.com
HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8
HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
-
2 weeks ago benzinga.com
HC Wainwright & Co. Maintains Buy on Alector, Raises Price Target to $8
HC Wainwright & Co. analyst Andrew S. Fein maintains Alector (NASDAQ:ALEC) with a Buy and raises the price target from $5 to $8.
2 weeks ago seekingalpha.com
Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments Transcript
Alector, Inc. (ALEC) Discusses Strategic Advances in Next Generation Neurodegeneration Therapies and Pipeline Developments Transcript
2 weeks ago marketbeat.com
Alector Maps Brain-Delivery Pipeline for Alzheimer's, Parkinson's Therapies
Alector NASDAQ: ALEC outlined its strategy to advance brain-penetrant therapies for neurodegenerative diseases, highlighting an anti-amyloid beta antibody for Alzheimer's disease and two siRNA…
3 weeks ago globenewswire.com
Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline
Agenda to feature progress for AL137, its lead anti-amyloid beta antibody; AL164, its tau siRNA program; and AL062, its alpha-synuclein siRNA program
-
3 weeks ago benzinga.com
Morgan Stanley Maintains Underweight on Alector, Raises Price Target to $3
Morgan Stanley analyst Sean Laaman maintains Alector (NASDAQ:ALEC) with a Underweight and raises the price target from $2 to $3.
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million. Alector…
-
3 weeks ago benzinga.com
Alector Teams Up With Genentech On Potential Parkinson’s Treatment
Alector, Inc. (NASDAQ:ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced it has entered into an exclusive…
3 weeks ago globenewswire.com
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson's Disease and Other Neurodegenerative Diseases
Alector grants Genentech exclusive rights to develop and commercialize AL050, an investigational GCase Enzyme Replacement Therapy (ERT) enabled by Alector Brain Carrier (ABC), Alector's proprietary…
1 month ago defenseworld.net
Contrasting Alector (NASDAQ:ALEC) & Ionis Pharmaceuticals (NASDAQ:IONS)
Alector (NASDAQ: ALEC - Get Free Report) and Ionis Pharmaceuticals (NASDAQ: IONS - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies…
1 month ago benzinga.com
Alpha Buying: Follow the Money From NVIDIA and Merck
Wall Street loves a good upgrade, especially when the stock has already doubled and the analyst can explain why everyone should have owned it six months ago. One place I look for ideas is the…
1 month ago seekingalpha.com
Alector, Inc. (ALEC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Alector, Inc. (ALEC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
1 month ago seekingalpha.com
Alector, Inc. (ALEC) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Prepared Remarks Transcript
Alector, Inc. (ALEC) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Prepared Remarks Transcript
1 month ago defenseworld.net
Comparing Alector (NASDAQ:ALEC) and Sarepta Therapeutics (NASDAQ:SRPT)
Alector (NASDAQ: ALEC - Get Free Report) and Sarepta Therapeutics (NASDAQ: SRPT - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two…
1 month ago globenewswire.com
Alector to Participate in Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million. NeuroSense Therapeutics (NASDAQ:NRSN) shares…
2 months ago zacks.com
Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates
Alector (ALEC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.3 per share a year ago.
2 months ago globenewswire.com
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector's lead ABC-enabled anti-amyloid beta (Aβ) antibody…
3 months ago benzinga.com
GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership
GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company moves to end its collaboration with Alector.
3 months ago reuters.com
Alector and GSK partnership to end after dementia, Alzheimer's drug failures
Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two experimental antibody drugs after both the drug candidates suffered clinical setbacks.
5 months ago zacks.com
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates
Alector (ALEC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.41 per share a year ago.
-
5 months ago benzinga.com
Alector Launches Up To $125M At-The-Market Common Stock Offering Through TD Cowen
$125,000,000Common StockWe have entered into a sales agreement with TD Securities (USA) LLC ("TD Cowen") relating to shares of our common stock offered by this prospectus supplement and the…
-
5 months ago benzinga.com
Alector Q1 EPS $(0.21) Beats $(0.35) Estimate, Sales $1.046M Miss $6.207M Estimate
Alector (NASDAQ:ALEC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.35) by 40 percent. This is a 48.78 percent increase over losses of $(0.41) per…
5 months ago globenewswire.com
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL037/AL137 (ABC-enabled antibody…
5 months ago zacks.com
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
6 months ago globenewswire.com
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer's Disease Following Interim Futility Analysis
--Independent data monitoring committee (IDMC) determined the trial unlikely to meet primary endpoint – --Alector remains focused on advancing its pipeline of novel ABC-enabled candidates, including…
6 months ago benzinga.com
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
7 months ago zacks.com
Alector (ALEC)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Alector, Inc. (ALEC) could be a good stock pick from a technical perspective. ALEC recently experienced a "golden cross" event, which saw its 50-day simple…
7 months ago 247wallst.com
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles
Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus for each.
7 months ago benzinga.com
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Wall Street analysts upgraded CRWD, ALEC, RIVN, SEDG, and DNTH. See what other analysts say about these stocks. Consider buying CRWD.
-
8 months ago benzinga.com
Alector Q4 EPS $(0.34) Beats $(0.39) Estimate, Sales $6.237M Beat $2.672M Estimate
Alector (NASDAQ:ALEC) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 13.71 percent. This is a 1600 percent decrease over losses of $(0.02) per…
1 year ago benzinga.com
Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results
Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
1 year ago benzinga.com
Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce
Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff.
-
1 year ago benzinga.com
HC Wainwright & Co. Maintains Buy on Alector, Lowers Price Target to $5
HC Wainwright & Co. analyst Andrew Fein maintains Alector (NASDAQ:ALEC) with a Buy and lowers the price target from $10 to $5.
1 year ago benzinga.com
Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings
Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings
1 year ago benzinga.com
Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Netflix Posts Downbeat Earnings, Joins Aveanna Healthcare, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
1 year ago benzinga.com
Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Why Intuitive Surgical Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
AT&T, Netflix And 3 Stocks To Watch Heading Into Wednesday
AT&T, Netflix And 3 Stocks To Watch Heading Into Wednesday
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Alector Discontinues Open-Label Extension For Latozinemab; Co To Reduce Workforce By About 49%
Alector Pipeline OutlookAlector remains focused on advancing a pipeline of programs designed to treat neurodegenerative diseases through mechanisms that remove toxic proteins, replace deficient…
1 year ago benzinga.com
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals
4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.
1 year ago benzinga.com
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge
Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.